BMA vs UCB
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
BMA
UCB
Investment Advisor Scores
UCB
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BMA | UCB | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 3.0979 | 12.5313 | BMA |
| PEG Ratio | 0.4681 | 1.674 | BMA |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.2% | 24.4% | UCB |
| Earnings Growth | 3.5% | 50.8% | UCB |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.0/100 | 45.2/100 | UCB |
| Profit Margin | 9.0% | 17.9% | UCB |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | UCB |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BMA
MarkdownPrice below a falling SMA50 (slope -9.6%), weak momentum, RSI 29
UCB
MarkupPrice above SMA50, rising 50-day trend (1.2% over 20 days), RSI 59
Fundamentals Snapshot
| Metric | BMA | UCB |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 10.9 |
| Trailing P/E | 11.8 | 31.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.2% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.3% | 7.7% |
| EPS | 4.89 | 1.19 |
| Dividend Yield | — | 0.03% |